🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45168K306 (prev. 45168K405 )
- Market Cap
- Micro Cap · $64 Million
- Previous Symbol
- IDP (changed 9/2/2005)
- Previous Name
- Hybridon, Inc.
Business: Idera Pharmaceuticals, Inc. is a clinical-stage patient-focused biopharmaceutical company developing novel nucleic acid therapeutic approaches for the treatment of certain cancers and rare diseases. Idera’s immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while our third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA.
Company Contact
- CEO
- Vincent Milano
- VPF
- John J. Kirby
- Headquarters
- 505 Eagleview Blvd., Suite 212, Exton, PA 19341
- Phone
- 484-348-1600
- Investor Relations
- Jill Conwell · 484-348-1675 · JConwell@IderaPharma.com